Abstract
Tumor-to-tumor metastasis is rare. Herein, we present a unique case of endometrial endometrioid adenocarcinoma metastatic to a thyroid Hürthle cell adenoma 9 years after initial diagnosis. On histologic examination of the thyroid, the malignant endometrioid glands and single cells (donor tumor) were dispersed within the Hürthle cell adenoma (recipient tumor). In several sections of the adenoma with still preserved microfollicular architecture, malignant endometrial adenocarcinoma cells were admixed within oncocytic adenomatous epithelium (so-called “cancerization of the follicles”). This unusual phenomenon, to our knowledge, is a novel finding in the thyroid gland. Immunohistochemistry, subsequently elicited clinical history, and morphologic comparison of the tumor in the thyroid to the primary endometrial tumor confirmed the origin of the donor tumor cells. Molecular analysis of both the metastatic and primary endometrial tumors demonstrated PIK3CA and PTEN mutations in both tumors, as is characteristic of well-differentiated endometrioid tumors of the endometrium. Amplification of chromosome 1q was detected in both sites; however, only the metastatic tumor showed loss of chromosomes 2, 9, and 22. The morphologic differential diagnosis of metastatic endometrioid adenocarcinoma in the thyroid includes columnar cell variant of papillary thyroid carcinoma (CCVPTC) arising in a preexisting adenoma, endocrine glandular atypia within an adenoma, and metastasis from other anatomic sites. Histomorphologic differences among these entities may be subtle; therefore, knowledge of and morphologic comparison with prior malignancies and immunohistochemistry can be helpful in rendering the correct diagnosis.
Similar content being viewed by others
References
Petraki C, Vaslamatzis M, Argyrakos T, Petraki K, Strataki M, Alexopoulos C, Sotsiou F. Tumor to tumor metastasis: report of two cases and review of the literature. Int J Surg Pathol 11:127–35, 2003.
Sella A, Ro JY. Renal cell cancer: best recipient of tumor-to-tumor metastasis. Urology 30:35–8, 1978.
Ro JY, Guerrieri C, el-Naggar AK, Ordóñez NG, Sorge JG, Ayala AG. Carcinomas metastatic to follicular adenomas of the thyroid gland. Report of two cases. Arch Pathol Lab Med 118:551–6, 1994.
Ro JY, Sahin AA, Ayala AG, Ordonez NG, Grignon DJ, Popok SM. Lung carcinoma with metastasis to testicular seminoma. Cancer 66:347–53, 1990.
Grignon DJ, Ro JY, Ayala AG. Malignant melanoma with metastasis to adenocarcinoma of the prostate. Cancer 63:196–8, 1989.
Grignon DJ, Ro JY, Varona OB, Ayala AG. Malignant melanoma with metastasis to a colonic polyp. Am J Gastroenterol 83:1298–300, 1988.
Yu J, Nikiforova MN, Hodak SP, Yim JH, Cai G, Walls A, Nikiforov YE, Seethala RR. Tumor-to-tumor metastases to follicular variant of papillary thyroid carcinoma: histologic, immunohistochemical, and molecular studies of two unusual cases. EndocrPathol 20:235–42, 2009.
Yeo SJ, Kim KJ, Kim BY, Jung CH, Lee SW, Kwak JJ, Kim CH, Kang SK, Mok JO. Metastasis of colon cancer to medullary thyroid carcinoma: a case report. J Korean Med Sci 29:1432–5, 2014.
Rosai J, Carcanjiu ML, DeLellis RA. Atlas of Tumor Pathology: tumors of the thyroid gland. 3rd series, Fascicle 5. Washington, DC: Armed Forces Institute of Pathology, 1992.
Hashimoto K, Yamamoto H, Nakano T, Oyama M, Shiratsuchi H, Nakashima T, Tamiya S, Komune S, Oda Y. Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to a follicular variant of papillary thyroid carcinoma. Pathol Int 61:435–41, 2011.
Bohn OL, De las Casas LE, Leon ME. Tumor-to-tumor metastasis: Renal cell carcinoma metastatic to papillary carcinoma of thyroid-report of a case and review of the literature. Head Neck Pathol 3:327–30, 2009.
Matsukuma S, Kono T, Takeo H, Hamakawa Y, Sato K. Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study. Virchows Arch 463:525–34, 2013.
Fadare O, Parkash V, Fiedler PN, Mayerson AB, Asiyanbola B. Tumor-to-tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma. Pathol Int 55:574–9, 2005.
Peteiro A, Duarte AM, Honavar M. Breast carcinoma metastatic to follicular adenoma of the thyroid gland. Histopathology 46:587–8, 2005.
Qian L, Pucci R, Castro CY, Eltorky MA. Renal cell carcinoma metastatic to Hurthle cell adenoma of thyroid. Ann Diagn Pathol 8:305–8, 2004.
Pusztaszeri M, Wang H, Cibas ES, Powers CN, Bongiovanni M, Ali S, Khurana KK, Michaels PJ, Faquin WC. Fine-needle aspiration biopsy of secondary neoplasms of the thyroid gland: A multi-institutional study of 62 cases. Cancer Cytopathol 123:19–29, 2015
McCluggage WG, Hurrell DP, Kennedy K. Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases. Am J Surg Pathol 34:735–41, 2010.
Jarboe EA, Miron A, Carlson JW, Hirsch MS, Kindelberger D, Mutter GL, Crum CP, Nucci MR. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol 28:308–15, 2009.
Kos Z, Broaddus RR, Djordjevic B. Fallopian tube high-grade serous carcinoma with intramucosal spread and presenting as a malignancy on pap smear. Int J Gynecol Pathol 33:443–8, 2014.
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER STAT Fact Sheet: Endometrial Cancer, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. Accessed 20 October 2015.
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet 2015. doi:10.1016/S0140-6736(15)00130-0
Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman LD. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. J Surg Oncol 2015 22. doi: 10.1002/jso.24049.
Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature 497:67–73, 2013. doi: 10.1038/nature12113. Erratum in: Nature 500:242, 2013
Pollak N, Renner GJ, Miick R, Frazier SR. Endometrioid adenocarcinoma metastatic to the thyroid, presenting like anaplastic thyroid cancer. Case Rep Endocrinol 2011:246872, 2011.
Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol 31:213–9, 2013.
McKenna, A. et al. The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297–1303, 2010.
DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet 43:491–498, 2011.
Van der Auwera, G. A. et al. From FastQ data to high-confidence variant calls: The genome analysis toolkit best practices pipeline. Curr. Protoc. Bioinforma 2013. doi:10.1002/0471250953.bi1110s43
Berent W. Seltene metastasenbildung. Zentralbl Allg Pathol Int 13:406–410, 1902.
Campbell LV Jr, Gilbert E, Chamberlain CR Jr, Watne AL. Metastases of cancer to cancer. Cancer 22:635–43, 1968.
Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: a review of the literature from the last decade. Thyroid 22:258–68, 2012.
Montero PH, Ibrahimpasic T, Nixon IJ, Shaha AR. Thyroid metastasectomy. J Surg Oncol 109:36–41, 2014.
Schröder S, Bürk CG, de Heer K. Metastases of the thyroid gland--morphology and clinical aspects of 25 secondary thyroid neoplasms. Langenbecks Arch Chir 370:25–35, 1987.
Wood K, Vini L, Harmer C. Metastases to the thyroid gland: the Royal Marsden experience. Eur J Surg Oncol 30:583–8, 2004.
Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 62:28–34; discussion 35–6, 2007.
Myriokefalitaki E, D’Costa D, Smith M, Ahmed AS. Primary bone metastasis as initial presentation of endometrial cancer (stage IVb). Arch Gynecol Obstet. 288:739–46, 2013.
Wimmer JL, Coffey DM, Kaplan AL, Ayala AG, Ro JY. Tumor-to-tumor metastasis with endometrial carcinoma metastatic to squamous cell carcinoma of vulva: the first reported case. Arch Pathol Lab Med 137:1825–8, 2013.
Chen JH, Faquin WC, Lloyd RV, Nosé V. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma. Mod Pathol 24:739–49, 2011.
Siami K, McCluggage WG, Ordonez NG, Euscher ED, Malpica A, Sneige N, Silva EG, Deavers MT. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J SurgPathol 31:1759–63, 2007.
Author information
Authors and Affiliations
Corresponding author
Additional information
Amir H. Afrogheh and Emily Meserve contributed equally to this work.
Rights and permissions
About this article
Cite this article
Afrogheh, A.H., Meserve, E., Sadow, P.M. et al. Molecular Characterization of an Endometrial Endometrioid Adenocarcinoma Metastatic to a Thyroid Hürthle Cell Adenoma Showing Cancerization of Follicles. Endocr Pathol 27, 213–219 (2016). https://doi.org/10.1007/s12022-015-9412-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-015-9412-5